Increased Levels of Specific Leukocyte- and Platelet-derived Substances during Normal Anti-tetanus Antibody Synthesis in Patients with Inactive Crohn Disease

References

• Sartor RB. Microbial factors in the pathogenesis of Crohn’s disease, ulcerative colitis, and experimental intestinal inflammation. In: Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease. 4th edn. Baltimore:Williams & Wilkins, 1995. p. 96–124.
   Google Scholar
• Reimund JM, Duclos B, Sapin R, Derlon A, Chamouard P, Baumann R, et al. Systemic tumour necrosis factor in Crohn’s disease: relationship to disease activity and circulation acute phase reactants. Eur J Gastroenterol Hepatol 1992;4:919–23.
   Web of Science ®Google Scholar
• Noguchi M, Hiwatashi N, Liu Z, Toyota T. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease. Gut 1998;43:203–9.
   PubMed Web of Science ®Google Scholar
• Song CH, Vadheim CM, Snape WJ, Heiner DC. Antibodies in patients with inflammatory bowel disease and the apparent influence of medications. J Clin Lab Immunol 1995;46:143–54.
   PubMedGoogle Scholar
• Stevens R, Oliver M, Brogan M, Heiserodt J, Targan S. Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn’s disease and ulcerative colitis patients. Gastroenterology 1985;88:1860–6.
   Google Scholar
• Brogan MD, Shanahan F, Oliver M, Stevens RH, Targan S. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. J Clin Lab Immunol 1987;24:69–74.
   Google Scholar
• Beck PL, Podolsky DK. Growth factors in inflammatory bowel disease. Inflammatory Bowel Diseases 1999;5:44–60.
   PubMed Web of Science ®Google Scholar
• Reinisch W, Gasche C, Tillinger W, Wyatt J, Lichtenberger C, Willheim M, et al. Clinical relevance of serum interleukin-6 in Crohn’s disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am J Gastroenterol 1999;94:2156–64.
   PubMed Web of Science ®Google Scholar
• Raithel M, Matek M, Baenkler HW, Jorde W, Hajn EG. Mucosal histamine and histamine reaction in Crohn’s disease, ulcerative colitis, and allergic enteropathy. Int Arch Allergy Immunol 1995;108:127–33.
   Google Scholar
• Griga T, Gutzeit A, Sommerkamp C, May B. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:175–9.
   PubMed Web of Science ®Google Scholar
• Vaalamo M, Kaijalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metallo-elastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 1998;152:1005–14.
   PubMed Web of Science ®Google Scholar
• Weber P, Husemann S, Vielhaber H, Zimmer KP, Nowak-Gottl U. Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999;28:418–22.
   Google Scholar
• Saiki T. Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease. Kurume Med J 1998; 45:69–73.
   PubMedGoogle Scholar
• Munkholm P, Langholz E, Kreiner S, Binder V. Incidence and prevalence of Crohn’s disease in the Copenhagen County from 1962–87: a six fold increase in incidence. Scand J Gastroenterol 1992;27:609–14.
   PubMed Web of Science ®Google Scholar
• Simonsen O, Bentzon MW, Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Standard 1986;14:231–9.
   Google Scholar
• Holten-Andersen MN, Murphy G, Nielsen HJ, Pedersen AN, Christensen IJ, Hoyer-Hansen G, et al. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer 1999;80: 495–503.
   Google Scholar
• Grøndahl-Hansen J, Christensen IJ, Rosenquist C, Brünner N, Mouridsen HT, Danø K, et al. High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 1993;53: 2513–21.
   Google Scholar
• Bousvaros A, Leichtner A, Zurakowski D, Kwon J, Law T, Keough K, et al. Elevated serum vascular endothelial growth factor in children and young adults with Crohn’s disease. Dig Dis Sci 1999;44:424–30.
   PubMed Web of Science ®Google Scholar
• Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 1998; 77:956–64.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Werther K, Mynster T, Brunner N. Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion 1999;39:1078–83.
   PubMed Web of Science ®Google Scholar
• Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503–21.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Edvardsen L, Vangsgaard K, Dybkjær E, Skov PS. Time-dependent histamine release from stored human blood products. Br J Surg 1996;83:157–62.
   Google Scholar
• Nielsen HJ, Hammer JH, Vangsgaard K, Veje H, Skov F, Mynster T. Bacteria-induced release of bioactive substances from white cells and platelets. Transfusion 1999;39 Suppl:38S.
   Google Scholar
• Kamath PS, Badakere SS, Mehta BC. Anti-idiotypic antibodies and circulating immune complexes after immunisation with tetanus toxoid. Ceylon Med J 1994;39:97–100.
   Google Scholar
• Fehr T, Bachmann MF, Bucher E, Kalinke U, Di Padova FE, Lang AB, et al. Role of repetitive antigen patterns for induction of antibodies against antibodies. J Exp Med 1997;185:1785–92.
   PubMed Web of Science ®Google Scholar
• Hansen MB, Svenson M, Diamant M, Bendtzen K. Antiinterleukin-6 antibodies in normal human serum. Scand J Immunol 1991;33:777–81.
   PubMed Web of Science ®Google Scholar
• Esnault VLM, Mathieson PW, Thiru S, Oliveira DBG, Lockwood CM. Autoantibodies to myeloperoxidase in brown Norway rats treated with mercuric chloride. Lab Invest 1992; 67:114–20.
   Google Scholar
• Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999;237:97–132.
   Google Scholar
• Bajou K, Noel A, Gerard R, Masson V, Briinner N, Holst-Hansen C, et al. Absence of host plasminogen activator inhibitor-1 prevents cancer invasion and vascularization. Nature Med 1998;4: 923–8.
   Google Scholar
• Nielsen HJ, Pappot H, Christensen J, Briinner N, Thorlacius-Ussing O, Moesgaard F, et al. Association of plasma concentrations of plasminogen activator inhibitor type-1 and survival in patients with colorectal cancer. Br Med J 1998;316: 829–30.
   Google Scholar
• Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology 1993;105:1716–23.
   PubMed Web of Science ®Google Scholar